West’s Director of Research Participated in the Clinical Trials for a COVID-19 Vaccine

Posted by & filed under Uncategorized.

Ari VanderWalde, MD, MPH, Bioeth, West Cancer Center and Research Institute’s Director of Research, stands behind the safety and highly regulated protocols for participants in clinical trials. Dr. VanderWalde recognized the importance and urgency to create a safe and effective vaccine to combat COVID-19. “I had a 50% chance of getting the vaccine and 50%… Read more »

West Physicians Publish a Study on the Establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting

Posted by & filed under Uncategorized.

West physicians Dr. Ari VanderWalde, Dr. Axel Grothey, Dr. Daniel Vaena, Dr. Gregorgy Vidal, Dr. Adam ElNaggar, & Dr. Lee Schwartzberg recently published a study on the establishment of a Molecular Tumor Board & Uptake of Recommendations in a Community Setting.   Abstract In the precision medicine era, molecular testing in advanced cancer is foundational… Read more »

Dr. Gregory Vidal Discusses Use of Patient Registries in Neratinib Study

Posted by & filed under Uncategorized.

Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer.   Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »

OneR and West Cancer Physicians Give Ten Presentations at SABCS

Posted by & filed under Uncategorized.

OneR and West Cancer Physicians Give Ten Presentations at SABCS   OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »

Grothey Published in NEJM for Colorectal Cancer Care

Posted by & filed under Uncategorized.

Axel Grothey, MD   The New England Journal of Medicine (NEJM) has recently published an editorial entitled “Pembrolizumab as first-line therapy in mismatch repair-deficient advanced colorectal cancer: A new standard of care” written by West Cancer Center’s GI Medical Oncology Lead and GI Oncology Clinical Research Director, Dr. Axel Grothey.   Click the link below… Read more »

West Cancer Center & Research Institute, through affiliate OneR & Genentech, Launches New Clinical Trial Targeting Actionable Mutation Study in Cancer

Posted by & filed under Uncategorized.

Matching patient populations with a targetable genomic alteration to a specific investigational study is the aim of a new clinical trial through OneR and Genentech. This partnership will facilitate collaborations on various clinical trials, scientific research and real-world data studies that will advance personalized cancer care at community oncology centers like West. “With too many… Read more »

Home

Posted by & filed under Uncategorized.

Patients and Family We understand how overwhelming a cancer diagnosis can be. Our physicians and staff are here to help patients and their loved ones navigate through the entire spectrum of care. More Information Appointment Information New Patient Paperwork Your Healthcare Team Care Support Services About Clinical Trials Activities & Events Oncology Departments Preventative Programs... Read more »

Your Appointment

Posted by & filed under Needs Review.

Your Appointment Your Diagnosis Patient Care Support Clinical Research Oncology Departments flyout-menu Home Patients and Family Your Appointment Your Diagnosis Your Diagnosis Anal Cancer Benign Blood Disorders Bladder Cancer Brain Cancer CNS Breast Cancer Cervical Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer Head and Neck Cancer Hepatobiliary Cancer Kidney Cancer Leukemia Lymphoma Melanoma Myeloma Non... Read more »